US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Can Fite Biofarma

1.20

-0.0300-2.44%

Post-market: 1.200.00000.00%19:53 EDT

Volume:349.49K

Turnover:427.01K

Market Cap:15.42M

PE:-1.10

High:1.27

Open:1.27

Low:1.18

Close:1.23

Loading ...

Overview Company News Filings

Can-Fite Biopharma Is Maintained at Buy by D. Boral Capital

Can-Fite reports disappearance of decompensated liver cirrhosis episodes

US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug

CanFite Biopharma (CANF) Upgraded to Strong Buy: Here's What You Should Know

Can-Fite Biopharma Is Maintained at Buy by D. Boral Capital

D. Boral says Can-Fite’s namodenoson may represent liver cancer ‘paradigm shift’

Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite’s anti-Cancer Drug Namodenoson

Bears are Losing Control Over CanFite Biopharma (CANF), Here's Why It's a 'Buy' Now

Can-Fite Biopharma Is Maintained at Buy by D. Boral Capital

Can-Fite BioPharma’s Namodenoson Shows Promising Cancer Results

Can-Fite announces 8 year survival for patient in Phase 2 Liver Cancer study

8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson Drug

Can-Fite BioPharma Advances in Pancreatic Cancer Trial

Can-Fite Biopharma Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer

MT Newswires Live

Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial

Can-Fite BioPharma Secures Australian Patent for Obesity Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CANF/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CANF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANF\",,,,,undefined,":{"symbol":"CANF","market":"US","secType":"STK","nameCN":"Can Fite Biofarma","latestPrice":1.2,"timestamp":1744920000000,"preClose":1.23,"halted":0,"volume":349492,"hourTrading":{"tag":"盘后","latestPrice":1.2,"preClose":1.2,"latestTime":"19:53 EDT","volume":529,"amount":635.0048,"timestamp":1744933998463},"delay":0,"floatShares":10451666,"shares":12853100,"eps":-1.0863,"marketStatus":"Market Closed","change":-0.03,"latestTime":"04-17 16:00:00 EDT","open":1.27,"high":1.27,"low":1.175,"amount":427006.84420680004,"amplitude":0.077236,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.0863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":300,"listingDate":1384837200000,"exchange":"AMEX","adjPreClose":1.23,"preHourTrading":{"tag":"盘前","latestPrice":1.2499,"preClose":1.23,"latestTime":"09:19 EDT","volume":67509,"amount":85161.45584699999,"timestamp":1744895973240},"postHourTrading":{"tag":"盘后","latestPrice":1.2,"preClose":1.2,"latestTime":"19:53 EDT","volume":529,"amount":635.0048,"timestamp":1744933998463},"volumeRatio":0.26976964842009143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CANF\",,,,,undefined,":{"symbol":"CANF","floatShares":10451666,"roa":"-53.18%","roe":"-134.94%","lyrEps":-1.0863,"volumeRatio":0.26976964842009143,"shares":12853100,"dividePrice":0,"high":1.27,"amplitude":0.077236,"preClose":1.23,"low":1.175,"week52Low":1.175,"pbRate":"2.84","psRate":"22.88","week52High":4.69,"institutionHeld":0,"latestPrice":1.2,"eps":-1.0863,"divideRate":0,"volume":349492,"delay":0,"ttmEps":-1.0863,"open":1.27,"prevYearClose":1.625,"prevWeekClose":1.57,"prevMonthClose":1.48,"prevQuarterClose":1.48,"fiveDayClose":1.398,"twentyDayClose":1.51,"sixtyDayClose":1.54},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CANF\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512951421","title":"Can-Fite Biopharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2512951421","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512951421?lang=en_us&edition=fundamental","pubTime":"2025-02-19 02:47","pubTimestamp":1739904420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CANF/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2025 13:47 ET (18:47 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"a1ddafff438fb4e9e17e4582ab2e0c11","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANF"],"gpt_icon":0},{"id":"2512151684","title":"Can-Fite reports disappearance of decompensated liver cirrhosis episodes","url":"https://stock-news.laohu8.com/highlight/detail?id=2512151684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512151684?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:22","pubTimestamp":1739881376,"startTime":"0","endTime":"0","summary":"Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis following tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/can-fite-reports-disappearance-of-decompensated-liver-cirrhosis-episodes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/can-fite-reports-disappearance-of-decompensated-liver-cirrhosis-episodes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANF","BK4139"],"gpt_icon":0},{"id":"2506237501","title":"US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2506237501","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506237501?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:00","pubTimestamp":1737979200,"startTime":"0","endTime":"0","summary":"The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety profile. The patent application No. 17/309,952 entitled “An A3 adenosine receptor ligand for use for achieving a fat loss effect”, has been accepted by the US Patent Office, will be issued on February 2nd and expires in 2042.Namodenoson is a small orally bioavailable drug that binds with high affinity and selectivity to the A3 adenosine receptor . Namodenoson is currently being evaluated in a pivotal Phase III trial for advanced liver cancer, a Phase IIb trial for the treatment of Metabolic Dysfunction-associated Steatohepatitis , and in a Phase IIa study in pancreatic cancer. A3AR is highly expressed in diseased cells whereas low expression is found in normal cells. This differential expression may be one of the important factors that accounts for the excellent safety profil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/us-patent-office-granted-fite-120000820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CANF","HCC","BK4006"],"gpt_icon":0},{"id":"2502026962","title":"CanFite Biopharma (CANF) Upgraded to Strong Buy: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2502026962","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502026962?lang=en_us&edition=fundamental","pubTime":"2025-01-10 01:00","pubTimestamp":1736442011,"startTime":"0","endTime":"0","summary":"Can-Fite Biopharma Ltd  could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 . An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for CanFite Biopharma basically reflects positivity about its earnings outlook that could translate into buying press","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/canfite-biopharma-canf-upgraded-strong-170011779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CANF"],"gpt_icon":0},{"id":"2495361622","title":"Can-Fite Biopharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2495361622","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495361622?lang=en_us&edition=fundamental","pubTime":"2024-12-31 23:05","pubTimestamp":1735657500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CANF/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 31, 2024 10:05 ET (15:05 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"3282fc865e13978d3af6ac6c40883b00","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANF"],"gpt_icon":0},{"id":"2495907416","title":"D. Boral says Can-Fite’s namodenoson may represent liver cancer ‘paradigm shift’","url":"https://stock-news.laohu8.com/highlight/detail?id=2495907416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495907416?lang=en_us&edition=fundamental","pubTime":"2024-12-31 21:40","pubTimestamp":1735652421,"startTime":"0","endTime":"0","summary":"D. Boral Capital notes that Can-Fite BioPharma (CANF) announced that its research on novel anti-cancer drug candidate namodenoson will be featured ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/d-boral-says-can-fites-namodenoson-may-represent-liver-cancer-paradigm-shift?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/d-boral-says-can-fites-namodenoson-may-represent-liver-cancer-paradigm-shift?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CANF"],"gpt_icon":0},{"id":"2495543037","title":"Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite’s anti-Cancer Drug Namodenoson","url":"https://stock-news.laohu8.com/highlight/detail?id=2495543037","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495543037?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:00","pubTimestamp":1735560000,"startTime":"0","endTime":"0","summary":"Can-Fite’s data will be presented at the 2025 ASCO Gastrointestinal Cancers Symposium. Can-Fite enrolls patients for its pivotal Phase III advanced liver cancer study. Currently, Namodenoson is being evaluated in a pivotal Phase 3 multinational registrational trial for the treatment of advanced liver cancer . Interestingly, Namodenoson has also completely cleared cancer in an HCC patient who was enrolled in Can-Fite’s Phase 2b HCC trial. The patient continues to be treated through a compassionate use program in Romania, where she remains cancer-free for more than 8 years following her first dose of Namodenoson.Namodenoson is a small orally bioavailable drug that binds with high affinity and selectivity to the A3 adenosine receptor . Namodenoson was evaluated in Phase II trials for two indications, as a second line treatment for hepatocellular carcinoma, and as a treatment for non-alcoholic fatty liver disease  and non-alcoholic steatohepatitis . A3AR is highly expressed in diseased cel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recognition-american-society-clinical-oncology-120000975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AFG","BK4107","BK4117","BK4006","CANF","HCC"],"gpt_icon":0},{"id":"2490777770","title":"Bears are Losing Control Over CanFite Biopharma (CANF), Here's Why It's a 'Buy' Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2490777770","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490777770?lang=en_us&edition=fundamental","pubTime":"2024-12-09 22:55","pubTimestamp":1733756105,"startTime":"0","endTime":"0","summary":"A downtrend has been apparent in Can-Fite Biopharma Ltd  lately. While the stock has lost 26.8% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the stock. On the fundamental side, strong agreement among Wall Street analysts in raising earnings estimates for this company enhances its prospects of a trend reversal.Understanding Hammer Chart and the Technique to Trade It. If this is not enough, you should note that CANF currently has a Zacks Rank #2 , which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bears-losing-control-over-canfite-145505076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CANF"],"gpt_icon":0},{"id":"2489430005","title":"Can-Fite Biopharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2489430005","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489430005?lang=en_us&edition=fundamental","pubTime":"2024-12-05 20:16","pubTimestamp":1733400960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CANF/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 05, 2024 07:16 ET (12:16 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"59a2679127ca760b272f65b3103c3082","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANF"],"gpt_icon":0},{"id":"2488607571","title":"Can-Fite BioPharma’s Namodenoson Shows Promising Cancer Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2488607571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488607571?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:28","pubTimestamp":1733315319,"startTime":"0","endTime":"0","summary":"Can-Fite BioPharma (CANF) has released an update. Can-Fite BioPharma’s drug Namodenoson has demonstrated remarkable results in treating advanced li...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/can-fite-biopharmas-namodenoson-shows-promising-cancer-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/can-fite-biopharmas-namodenoson-shows-promising-cancer-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANF","BK4139"],"gpt_icon":0},{"id":"2488167996","title":"Can-Fite announces 8 year survival for patient in Phase 2 Liver Cancer study","url":"https://stock-news.laohu8.com/highlight/detail?id=2488167996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488167996?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:11","pubTimestamp":1733314310,"startTime":"0","endTime":"0","summary":"Can-Fite BioPharma (CANF) announced that a patient currently treated with Namodenoson in a compassionate use program in Can-Fite’s Phase II Liver C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/can-fite-announces-8-year-survival-for-patient-in-phase-2-liver-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/can-fite-announces-8-year-survival-for-patient-in-phase-2-liver-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CANF"],"gpt_icon":0},{"id":"2488162503","title":"8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2488162503","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488162503?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:00","pubTimestamp":1733313600,"startTime":"0","endTime":"0","summary":"RAMAT GAN, Israel, Dec. 04, 2024  -- Can-Fite BioPharma Ltd.  , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announced today that a patient currently treated with Namodenoson in a compassionate use program in Can-Fite’s Phase II Liver Cancer Study has an overall survival time of 8 years with a complete response.Can-Fite is currently enrolling patients in Israel, Europe and the US for a pivotal Phase III clinical study for patients with advanced HCC as a 2nd or 3rd line treatment and Namodenoson is administered twice daily orally. The study protocol has been agreed upon with U.S. Food and Drug Administration  and European Medicines Agency .Namodenoson has Orphan Drug status with both the FDA and EMA, as well as Fast Track Status with the FDA for the treatment of HCC. A compassionate use program has been ongoing in Israel and Romania.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sJtGBGhYav13.OX82J5L2A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6114327b6294df8bacb7f8b771866c2b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sJtGBGhYav13.OX82J5L2A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6114327b6294df8bacb7f8b771866c2b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/8-years-survival-complete-cure-120000894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IE00B66KJ199.SGD","IE0031619046.USD","AEIS","BK4006","BK4157","IE00B19Z4B17.USD","IE00B7SZL793.SGD","HCC","CANF"],"gpt_icon":0},{"id":"2483080385","title":"Can-Fite BioPharma Advances in Pancreatic Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2483080385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483080385?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:52","pubTimestamp":1731426727,"startTime":"0","endTime":"0","summary":"Can-Fite BioPharma (CANF) has released an update. Can-Fite BioPharma has achieved a significant milestone by dosing the first patient in its Phase ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/can-fite-biopharma-advances-in-pancreatic-cancer-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/can-fite-biopharma-advances-in-pancreatic-cancer-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANF","BK4139"],"gpt_icon":0},{"id":"2482870873","title":"Can-Fite Biopharma Price Target Maintained With a $18.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2482870873","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482870873?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:03","pubTimestamp":1731412980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CANF/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 12, 2024 07:03 ET (12:03 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANF"],"gpt_icon":0},{"id":"2482783992","title":"Can-Fite BioPharma Doses First Patient in Namodenoson Phase 2a Trial in Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2482783992","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482783992?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:33","pubTimestamp":1731328388,"startTime":"0","endTime":"0","summary":"Can-Fite BioPharma  said Monday that the first patient has been dosed in its phase 2a trial of Namodenoson in patients with advanced pancreatic adenocarcinoma.The company said it targets to enroll about 20 evaluable patients in the trial.The study's primary objective is to characterize Namodenoson's safety profile, while the secondary objective is to evaluate clinical activity using overall response rate, overall survival, and progression-free survival, among others, Can-Fite added.Price: 2.7500, Change: -0.07, Percent Change: -2.48","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CANF","BK4139"],"gpt_icon":0},{"id":"2482053200","title":"Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2482053200","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482053200?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:00","pubTimestamp":1731326400,"startTime":"0","endTime":"0","summary":"RAMAT GAN, Israel, Nov. 11, 2024  -- Can-Fite BioPharma Ltd.  , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announces the dosing of the first patient in the Phase IIa clinical trial in patients with advanced pancreatic adenocarcinoma .“We are excited to have the first patient enrolled and hope that we will be able to demonstrate the safety and efficacy of Namodenoson in the pancreatic cancer patient population. This trial provides us the opportunity to explore our innovative treatment approach for patients who are facing significant gaps in effective treatment options,” stated Dr. Michael Silverman, Can-Fite’s Medical Officer.Can-Fite BioPharma Ltd.   is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The Company's lead drug candidate, Piclidenos","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sJtGBGhYav13.OX82J5L2A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6114327b6294df8bacb7f8b771866c2b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sJtGBGhYav13.OX82J5L2A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/6114327b6294df8bacb7f8b771866c2b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fite-achieves-milestone-first-patient-120000494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","CANF","PK","HCC","OS","BK4218","BK4195","PFS","BK4097","BK4211","BK4139","BK4006"],"gpt_icon":0},{"id":"2481503034","title":"Can-Fite BioPharma Secures Australian Patent for Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2481503034","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481503034?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:28","pubTimestamp":1730809686,"startTime":"0","endTime":"0","summary":"Can-Fite BioPharma Ltd. has received a patent allowance in Australia for its oral anti-obesity drug Namodenoson, which has demonstrated a promising safety profile. The patent, valid until 2040, covers methods of treating obesity by increasing adiponectin hormone levels to reduce body fat. This advancement positions Can-Fite in the lucrative global obesity treatment market, valued at $12 billion in 2023.For further insights into CANF stock, check out TipRanks’ Stock Analysis page.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BemfyP1UBzXHKKZLDQ1ooQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/c37c6416e3d93ec36371ae85ba3ad4a9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BemfyP1UBzXHKKZLDQ1ooQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/c37c6416e3d93ec36371ae85ba3ad4a9"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fite-biopharma-secures-australian-patent-122806062.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fite-biopharma-secures-australian-patent-122806062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CANF"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CANF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-14","symbol":"CANF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1744603200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-08-29","symbol":"CANF","fiscalQuarterEnding":"2024/06","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1724904000000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2024-03-28","symbol":"CANF","fiscalQuarterEnding":"2023/12","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"pre","actualEps":-0.31},{"market":"US","date":"2023-11-30","symbol":"CANF","fiscalQuarterEnding":"2023/09","expectedEps":-0.43,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1701320400000,"reportTimeType":"pre","actualEps":-0.43},{"market":"US","date":"2023-08-31","symbol":"CANF","fiscalQuarterEnding":"2023/06","expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1693454400000,"reportTimeType":"pre","actualEps":-0.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CANF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CANF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CANF\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CANF","date":"2025-04-17","current":-2.142187,"percent":0.320097,"low":-3.950254,"twenty":-2.555599,"median":-1.897777,"eighty":-1.313534,"high":-0.691997,"avg":-1.925305,"sd":0.670591,"marketCap":16880431.15},"quantilePoints":[{"date":"2020-04-24","current":-1.288918,"twenty":-4.968646,"median":-4.115768,"eighty":-1.288918,"marketCap":16272592.62},{"date":"2020-05-01","current":-1.369944,"twenty":-4.968624,"median":-4.101403,"eighty":-1.289032,"marketCap":17295539.19},{"date":"2020-05-08","current":-1.286603,"twenty":-4.956176,"median":-4.098391,"eighty":-1.288918,"marketCap":16243362.88},{"date":"2020-05-15","current":-1.25758,"twenty":-4.953389,"median":-4.094068,"eighty":-1.287362,"marketCap":15876948.21},{"date":"2020-05-22","current":-1.562024,"twenty":-4.943599,"median":-4.084876,"eighty":-1.288396,"marketCap":19720551.95},{"date":"2020-05-29","current":-1.61433,"twenty":-4.943599,"median":-4.083007,"eighty":-1.288814,"marketCap":20380911.19},{"date":"2020-06-05","current":-1.696723,"twenty":-4.943599,"median":-4.055914,"eighty":-1.289009,"marketCap":20525260.2},{"date":"2020-06-12","current":-1.971881,"twenty":-4.943396,"median":-4.053983,"eighty":-1.291632,"marketCap":23853845.12},{"date":"2020-06-19","current":-1.991437,"twenty":-4.9366,"median":-4.050766,"eighty":-1.29249,"marketCap":24090419.03},{"date":"2020-06-26","current":-2.051678,"twenty":-4.934348,"median":-4.034676,"eighty":-1.294842,"marketCap":24819146.65},{"date":"2020-07-02","current":-2.271694,"twenty":-4.934206,"median":-4.018586,"eighty":-1.296669,"marketCap":27480687.39},{"date":"2020-07-10","current":-2.332739,"twenty":-4.930449,"median":-4.005714,"eighty":-1.298502,"marketCap":28219142.18},{"date":"2020-07-17","current":-2.4804,"twenty":-4.92002,"median":-3.992198,"eighty":-1.302911,"marketCap":30005394.71},{"date":"2020-07-24","current":-3.135846,"twenty":-4.910939,"median":-3.983832,"eighty":-1.306287,"marketCap":37934328.2},{"date":"2020-07-31","current":-3.122137,"twenty":-4.906221,"median":-3.958089,"eighty":-1.309324,"marketCap":37768490.17},{"date":"2020-08-07","current":-2.84541,"twenty":-4.902789,"median":-3.954227,"eighty":-1.313722,"marketCap":34420931.04},{"date":"2020-08-14","current":-2.738523,"twenty":-4.893741,"median":-3.938736,"eighty":-1.330837,"marketCap":33127909.8},{"date":"2020-08-21","current":-2.967435,"twenty":-4.887777,"median":-3.906601,"eighty":-1.343754,"marketCap":35897064.81},{"date":"2020-08-28","current":-2.137339,"twenty":-4.885714,"median":-3.901452,"eighty":-1.346364,"marketCap":34126897.39},{"date":"2020-09-04","current":-1.845576,"twenty":-4.878796,"median":-3.901452,"eighty":-1.348209,"marketCap":29468309.92},{"date":"2020-09-11","current":-1.691811,"twenty":-4.873976,"median":-3.896304,"eighty":-1.356637,"marketCap":27013138.32},{"date":"2020-09-18","current":-1.830558,"twenty":-4.870456,"median":-3.879714,"eighty":-1.368754,"marketCap":29228514.91},{"date":"2020-09-25","current":-1.680294,"twenty":-4.862673,"median":-3.864124,"eighty":-1.372932,"marketCap":26829254.08},{"date":"2020-10-02","current":-1.730246,"twenty":-4.855023,"median":-3.86155,"eighty":-1.381358,"marketCap":27626843.76},{"date":"2020-10-09","current":-1.834816,"twenty":-4.853275,"median":-3.86155,"eighty":-1.387753,"marketCap":29296514},{"date":"2020-10-16","current":-1.970832,"twenty":-4.850748,"median":-3.844172,"eighty":-1.388567,"marketCap":31468275.05},{"date":"2020-10-23","current":-1.77585,"twenty":-4.847764,"median":-3.82755,"eighty":-1.389345,"marketCap":28355005.63},{"date":"2020-10-30","current":-1.708736,"twenty":-4.845788,"median":-3.817854,"eighty":-1.390851,"marketCap":27283386.27},{"date":"2020-11-06","current":-1.725399,"twenty":-4.840222,"median":-3.804914,"eighty":-1.392388,"marketCap":27549443.36},{"date":"2020-11-13","current":-1.788562,"twenty":-4.832072,"median":-3.799765,"eighty":-1.393563,"marketCap":28557971.5},{"date":"2020-11-20","current":-1.757012,"twenty":-4.825022,"median":-3.761149,"eighty":-1.395115,"marketCap":28054212.26},{"date":"2020-11-27","current":-1.814193,"twenty":-4.822955,"median":-3.753426,"eighty":-1.397656,"marketCap":28967224.28},{"date":"2020-12-04","current":-1.854788,"twenty":-4.819722,"median":-3.752139,"eighty":-1.40145,"marketCap":28923561.6},{"date":"2020-12-11","current":-1.900219,"twenty":-4.816259,"median":-3.745801,"eighty":-1.411489,"marketCap":29632010.81},{"date":"2020-12-18","current":-1.892645,"twenty":-4.808936,"median":-3.728326,"eighty":-1.42155,"marketCap":29513904.54},{"date":"2020-12-24","current":-1.886919,"twenty":-4.80029,"median":-3.708375,"eighty":-1.421576,"marketCap":29424616.68},{"date":"2020-12-31","current":-1.840957,"twenty":-4.799813,"median":-3.700652,"eighty":-1.421893,"marketCap":28707889.45},{"date":"2021-01-08","current":-1.904571,"twenty":-4.797036,"median":-3.695503,"eighty":-1.425087,"marketCap":29699880.71},{"date":"2021-01-15","current":-1.866448,"twenty":-4.793877,"median":-3.678126,"eighty":-1.426309,"marketCap":29105384.66},{"date":"2021-01-22","current":-1.900481,"twenty":-4.789536,"median":-3.674908,"eighty":-1.427843,"marketCap":29636096.43},{"date":"2021-01-29","current":-1.905496,"twenty":-4.787057,"median":-3.668472,"eighty":-1.431728,"marketCap":29714299.18},{"date":"2021-02-05","current":-2.052299,"twenty":-4.785355,"median":-3.644016,"eighty":-1.43707,"marketCap":32003547.04},{"date":"2021-02-12","current":-2.643374,"twenty":-4.77875,"median":-3.62857,"eighty":-1.443386,"marketCap":41220782.41},{"date":"2021-02-19","current":-2.319903,"twenty":-4.774965,"median":-3.614862,"eighty":-1.450816,"marketCap":36176571.73},{"date":"2021-02-26","current":-2.442344,"twenty":-4.771759,"median":-3.597274,"eighty":-1.458997,"marketCap":38085914.46},{"date":"2021-03-05","current":-2.084696,"twenty":-4.765258,"median":-3.589954,"eighty":-1.460871,"marketCap":32508743.06},{"date":"2021-03-12","current":-2.159686,"twenty":-4.757771,"median":-3.548121,"eighty":-1.461365,"marketCap":33678134.8},{"date":"2021-03-19","current":-3.113166,"twenty":-4.745904,"median":-3.496878,"eighty":-1.461587,"marketCap":48546704.23},{"date":"2021-03-26","current":-2.754437,"twenty":-4.733254,"median":-3.493617,"eighty":-1.46323,"marketCap":39782338.98},{"date":"2021-04-01","current":-2.906666,"twenty":-4.723753,"median":-3.487758,"eighty":-1.466068,"marketCap":41980970.47},{"date":"2021-04-09","current":-2.821566,"twenty":-4.70949,"median":-3.470246,"eighty":-1.467735,"marketCap":40751872.36},{"date":"2021-04-16","current":-2.754894,"twenty":-4.683577,"median":-3.293992,"eighty":-1.468683,"marketCap":39788928.46},{"date":"2021-04-23","current":-2.709139,"twenty":-4.673718,"median":-3.25997,"eighty":-1.470383,"marketCap":39128093.5},{"date":"2021-04-30","current":-2.673313,"twenty":-4.673218,"median":-3.192214,"eighty":-1.470867,"marketCap":38610662.37},{"date":"2021-05-07","current":-2.505361,"twenty":-4.672492,"median":-3.165184,"eighty":-1.471738,"marketCap":36184925.99},{"date":"2021-05-14","current":-2.539206,"twenty":-4.67029,"median":-3.153844,"eighty":-1.474434,"marketCap":36673752.86},{"date":"2021-05-21","current":-2.599298,"twenty":-4.667992,"median":-3.136581,"eighty":-1.476821,"marketCap":37541653.92},{"date":"2021-05-28","current":-3.073408,"twenty":-4.663884,"median":-3.133138,"eighty":-1.479343,"marketCap":36816350.46},{"date":"2021-06-04","current":-3.01986,"twenty":-4.653559,"median":-3.122333,"eighty":-1.486421,"marketCap":36174907.4},{"date":"2021-06-11","current":-3.133956,"twenty":-4.651864,"median":-3.12253,"eighty":-1.487837,"marketCap":37541653.92},{"date":"2021-06-18","current":-3.334177,"twenty":-4.650778,"median":-3.13302,"eighty":-1.489589,"marketCap":39940107.32},{"date":"2021-06-25","current":-3.215963,"twenty":-4.650694,"median":-3.135938,"eighty":-1.4918,"marketCap":38524022.19},{"date":"2021-07-02","current":-3.236664,"twenty":-4.643052,"median":-3.141494,"eighty":-1.493032,"marketCap":38771991.57},{"date":"2021-07-09","current":-3.150692,"twenty":-4.640954,"median":-3.147449,"eighty":-1.497999,"marketCap":37742136.24},{"date":"2021-07-16","current":-3.24493,"twenty":-4.639343,"median":-3.150923,"eighty":-1.500215,"marketCap":38871016.56},{"date":"2021-07-23","current":-3.210741,"twenty":-4.638673,"median":-3.153844,"eighty":-1.50091,"marketCap":38461473.46},{"date":"2021-07-30","current":-3.065874,"twenty":-4.638165,"median":-3.150692,"eighty":-1.504474,"marketCap":36726105.14},{"date":"2021-08-06","current":-2.989968,"twenty":-4.630758,"median":-3.14524,"eighty":-1.506147,"marketCap":35816824.99},{"date":"2021-08-13","current":-2.972857,"twenty":-4.625776,"median":-3.13839,"eighty":-1.509087,"marketCap":35611855.62},{"date":"2021-08-20","current":-3.04012,"twenty":-4.615229,"median":-3.136259,"eighty":-1.51124,"marketCap":36417598.62},{"date":"2021-08-27","current":-3.175482,"twenty":-4.611458,"median":-3.135938,"eighty":-1.512549,"marketCap":35898830.52},{"date":"2021-09-03","current":-2.926034,"twenty":-4.606711,"median":-3.136259,"eighty":-1.513055,"marketCap":33078816.18},{"date":"2021-09-10","current":-3.02197,"twenty":-4.605606,"median":-3.134901,"eighty":-1.516358,"marketCap":34163374.35},{"date":"2021-09-17","current":-3.049614,"twenty":-4.605008,"median":-3.13043,"eighty":-1.519172,"marketCap":34475886.22},{"date":"2021-09-24","current":-3.024899,"twenty":-4.604519,"median":-3.122333,"eighty":-1.519789,"marketCap":34196480.46},{"date":"2021-10-01","current":-3.028697,"twenty":-4.602036,"median":-3.119204,"eighty":-1.52046,"marketCap":34239416.01},{"date":"2021-10-08","current":-2.834399,"twenty":-4.594995,"median":-3.107451,"eighty":-1.521284,"marketCap":32042879.87},{"date":"2021-10-15","current":-2.907502,"twenty":-4.589602,"median":-3.093031,"eighty":-1.525888,"marketCap":32869307.63},{"date":"2021-10-22","current":-2.982517,"twenty":-4.586958,"median":-3.077432,"eighty":-1.533333,"marketCap":33717350.42},{"date":"2021-10-29","current":-3.004236,"twenty":-4.585502,"median":-3.073408,"eighty":-1.537345,"marketCap":33962892.9},{"date":"2021-11-05","current":-2.991524,"twenty":-4.581581,"median":-3.065932,"eighty":-1.54044,"marketCap":33819177.4},{"date":"2021-11-12","current":-2.811155,"twenty":-4.578265,"median":-3.064746,"eighty":-1.551216,"marketCap":31780108.69},{"date":"2021-11-19","current":-2.62543,"twenty":-4.576446,"median":-3.056029,"eighty":-1.560138,"marketCap":29680489.76},{"date":"2021-11-26","current":-2.273497,"twenty":-4.574977,"median":-3.049899,"eighty":-1.562543,"marketCap":27577515.22},{"date":"2021-12-03","current":-2.099655,"twenty":-4.573568,"median":-3.046099,"eighty":-1.564916,"marketCap":25468810.59},{"date":"2021-12-10","current":-2.194238,"twenty":-4.571631,"median":-3.043686,"eighty":-1.570889,"marketCap":26616114.26},{"date":"2021-12-17","current":-2.125119,"twenty":-4.567993,"median":-3.04012,"eighty":-1.576601,"marketCap":25777696.32},{"date":"2021-12-23","current":-3.180138,"twenty":-4.565426,"median":-3.043454,"eighty":-1.577863,"marketCap":38575072.84},{"date":"2021-12-31","current":-3.178406,"twenty":-4.565106,"median":-3.043686,"eighty":-1.581981,"marketCap":38554063.92},{"date":"2022-01-07","current":-3.028709,"twenty":-4.564378,"median":-3.043832,"eighty":-1.58643,"marketCap":36738236.18},{"date":"2022-01-14","current":-3.070395,"twenty":-4.561702,"median":-3.046701,"eighty":-1.588888,"marketCap":37243898.46},{"date":"2022-01-21","current":-2.999664,"twenty":-4.560122,"median":-3.044776,"eighty":-1.598089,"marketCap":36385918.06},{"date":"2022-01-28","current":-2.606194,"twenty":-4.558944,"median":-3.043454,"eighty":-1.598177,"marketCap":31613132.48},{"date":"2022-02-04","current":-2.559359,"twenty":-4.558944,"median":-3.034486,"eighty":-1.598884,"marketCap":31045028.23},{"date":"2022-02-11","current":-2.619494,"twenty":-4.554827,"median":-3.028979,"eighty":-1.603544,"marketCap":31774462.72},{"date":"2022-02-18","current":-2.580257,"twenty":-4.547045,"median":-3.02442,"eighty":-1.603544,"marketCap":31298519.56},{"date":"2022-02-25","current":-2.577915,"twenty":-4.540682,"median":-3.02044,"eighty":-1.603544,"marketCap":31270106.34},{"date":"2022-03-04","current":-2.631302,"twenty":-4.533343,"median":-3.012735,"eighty":-1.603544,"marketCap":31917688.15},{"date":"2022-03-11","current":-2.336229,"twenty":-4.526168,"median":-3.002867,"eighty":-1.603544,"marketCap":28338456.41},{"date":"2022-03-18","current":-2.218524,"twenty":-4.519203,"median":-2.992333,"eighty":-1.603544,"marketCap":26910699.24},{"date":"2022-03-25","current":-2.291794,"twenty":-4.501556,"median":-2.983811,"eighty":-1.603544,"marketCap":28910985.82},{"date":"2022-04-01","current":-2.442618,"twenty":-4.479434,"median":-2.971993,"eighty":-1.603544,"marketCap":30813630.01},{"date":"2022-04-08","current":-2.4476,"twenty":-4.465486,"median":-2.96558,"eighty":-1.603544,"marketCap":30876472.76},{"date":"2022-04-14","current":-2.349475,"twenty":-4.458901,"median":-2.950611,"eighty":-1.603544,"marketCap":29638629.9},{"date":"2022-04-22","current":-2.373092,"twenty":-4.456116,"median":-2.938021,"eighty":-1.603544,"marketCap":29936559.22},{"date":"2022-04-29","current":-2.150649,"twenty":-4.451322,"median":-2.927293,"eighty":-1.603544,"marketCap":27130438.35},{"date":"2022-05-06","current":-2.095671,"twenty":-4.44681,"median":-2.907084,"eighty":-1.603544,"marketCap":26436889.99},{"date":"2022-05-13","current":-1.954307,"twenty":-4.419912,"median":-2.884181,"eighty":-1.603544,"marketCap":24653580.59},{"date":"2022-05-20","current":-1.998199,"twenty":-4.390732,"median":-2.860594,"eighty":-1.603544,"marketCap":25207277.75},{"date":"2022-05-27","current":-1.887304,"twenty":-4.379344,"median":-2.846621,"eighty":-1.603544,"marketCap":24857682.61},{"date":"2022-06-03","current":-1.945603,"twenty":-4.379344,"median":-2.831679,"eighty":-1.603544,"marketCap":25625537.77},{"date":"2022-06-10","current":-1.9516,"twenty":-4.379344,"median":-2.806235,"eighty":-1.603544,"marketCap":25704524.25},{"date":"2022-06-17","current":-1.787653,"twenty":-4.379344,"median":-2.771815,"eighty":-1.603544,"marketCap":23545179.53},{"date":"2022-06-24","current":-1.81086,"twenty":-4.380291,"median":-2.754437,"eighty":-1.602379,"marketCap":23850835.92},{"date":"2022-07-01","current":-1.863078,"twenty":-4.380291,"median":-2.7421,"eighty":-1.602379,"marketCap":24538596.69},{"date":"2022-07-08","current":-1.808819,"twenty":-4.380291,"median":-2.737769,"eighty":-1.602379,"marketCap":23823952.52},{"date":"2022-07-15","current":-1.84022,"twenty":-4.380291,"median":-2.706562,"eighty":-1.602379,"marketCap":24237543.41},{"date":"2022-07-22","current":-1.838102,"twenty":-4.380291,"median":-2.679918,"eighty":-1.602379,"marketCap":24209642.7},{"date":"2022-07-29","current":-1.85898,"twenty":-4.380291,"median":-2.663797,"eighty":-1.602379,"marketCap":24484630.84},{"date":"2022-08-05","current":-1.880842,"twenty":-4.380291,"median":-2.645686,"eighty":-1.602379,"marketCap":24772573.84},{"date":"2022-08-12","current":-1.910337,"twenty":-4.380291,"median":-2.632148,"eighty":-1.602379,"marketCap":25161046.54},{"date":"2022-08-19","current":-1.891897,"twenty":-4.380291,"median":-2.624266,"eighty":-1.602379,"marketCap":24918174.85},{"date":"2022-08-26","current":-2.096496,"twenty":-4.380291,"median":-2.609701,"eighty":-1.602379,"marketCap":25457753.33},{"date":"2022-09-02","current":-2.032808,"twenty":-4.380291,"median":-2.601916,"eighty":-1.602379,"marketCap":24684383.83},{"date":"2022-09-09","current":-1.990907,"twenty":-4.380291,"median":-2.59125,"eighty":-1.602379,"marketCap":24175579.52},{"date":"2022-09-16","current":-2.032863,"twenty":-4.380291,"median":-2.572359,"eighty":-1.602379,"marketCap":24685059.94},{"date":"2022-09-23","current":-1.914239,"twenty":-4.380291,"median":-2.559984,"eighty":-1.602379,"marketCap":23244608.48},{"date":"2022-09-30","current":-1.867322,"twenty":-4.380291,"median":-2.539206,"eighty":-1.602379,"marketCap":22674888.53},{"date":"2022-10-07","current":-1.861737,"twenty":-4.380291,"median":-2.520693,"eighty":-1.602379,"marketCap":22607074.26},{"date":"2022-10-14","current":-1.833098,"twenty":-4.380291,"median":-2.507732,"eighty":-1.602379,"marketCap":22259308.54},{"date":"2022-10-21","current":-1.817165,"twenty":-4.380291,"median":-2.497598,"eighty":-1.602379,"marketCap":22065833.76},{"date":"2022-10-28","current":-1.824155,"twenty":-4.380291,"median":-2.476596,"eighty":-1.602379,"marketCap":22150716.75},{"date":"2022-11-04","current":-1.876542,"twenty":-4.380291,"median":-2.466842,"eighty":-1.602379,"marketCap":22786852.23},{"date":"2022-11-11","current":-1.906353,"twenty":-4.380291,"median":-2.446006,"eighty":-1.602379,"marketCap":23148847.35},{"date":"2022-11-18","current":-1.860251,"twenty":-4.380291,"median":-2.440589,"eighty":-1.602379,"marketCap":22589028.5},{"date":"2022-11-25","current":-2.070712,"twenty":-4.380291,"median":-2.417039,"eighty":-1.602379,"marketCap":23341061.61},{"date":"2022-12-02","current":-2.06041,"twenty":-4.380291,"median":-2.392703,"eighty":-1.602379,"marketCap":23224945.7},{"date":"2022-12-09","current":-1.946775,"twenty":-4.380291,"median":-2.373092,"eighty":-1.602379,"marketCap":21944052.05},{"date":"2022-12-16","current":-1.797682,"twenty":-4.380291,"median":-2.347053,"eighty":-1.602379,"marketCap":20263476.21},{"date":"2022-12-23","current":-1.755483,"twenty":-4.380291,"median":-2.332739,"eighty":-1.602379,"marketCap":19787801.15},{"date":"2022-12-30","current":-1.728811,"twenty":-4.380291,"median":-2.316219,"eighty":-1.598601,"marketCap":19487156.39},{"date":"2023-01-06","current":-1.443879,"twenty":-4.380291,"median":-2.297405,"eighty":-1.58575,"marketCap":16275399.74},{"date":"2023-01-13","current":-1.552591,"twenty":-4.356576,"median":-2.288234,"eighty":-1.57268,"marketCap":17500806.55},{"date":"2023-01-20","current":-1.392365,"twenty":-4.333392,"median":-2.273497,"eighty":-1.560138,"marketCap":15694743.16},{"date":"2023-01-27","current":-1.052882,"twenty":-4.296365,"median":-2.262264,"eighty":-1.535667,"marketCap":11868090.44},{"date":"2023-02-03","current":-1.227427,"twenty":-4.273291,"median":-2.219795,"eighty":-1.52046,"marketCap":13835562.67},{"date":"2023-02-10","current":-1.146649,"twenty":-4.253257,"median":-2.194238,"eighty":-1.512987,"marketCap":12925024.76},{"date":"2023-02-17","current":-0.981098,"twenty":-4.237477,"median":-2.170555,"eighty":-1.504002,"marketCap":11058934.51},{"date":"2023-02-24","current":-0.92453,"twenty":-4.228785,"median":-2.160141,"eighty":-1.496757,"marketCap":10421300.15},{"date":"2023-03-03","current":-0.87331,"twenty":-4.18459,"median":-2.145358,"eighty":-1.483041,"marketCap":9843948.8},{"date":"2023-03-10","current":-0.86563,"twenty":-4.140693,"median":-2.125119,"eighty":-1.471034,"marketCap":9757378.27},{"date":"2023-03-17","current":-0.744984,"twenty":-4.00316,"median":-2.102846,"eighty":-1.464048,"marketCap":8397453.99},{"date":"2023-03-24","current":-0.734515,"twenty":-3.608698,"median":-2.096881,"eighty":-1.453178,"marketCap":8279448.73},{"date":"2023-03-31","current":-0.81425,"twenty":-3.431,"median":-2.083496,"eighty":-1.428561,"marketCap":8283369.36},{"date":"2023-04-06","current":-0.932153,"twenty":-3.334786,"median":-2.071741,"eighty":-1.421893,"marketCap":9482786.87},{"date":"2023-04-14","current":-0.691997,"twenty":-3.260336,"median":-2.060561,"eighty":-1.398612,"marketCap":7039680.61},{"date":"2023-04-21","current":-0.726022,"twenty":-3.245814,"median":-2.056948,"eighty":-1.392092,"marketCap":7385818.99},{"date":"2023-04-28","current":-0.728398,"twenty":-3.225833,"median":-2.046606,"eighty":-1.387322,"marketCap":7409988.18},{"date":"2023-05-05","current":-0.757217,"twenty":-3.206779,"median":-2.03872,"eighty":-1.348209,"marketCap":7703169.18},{"date":"2023-05-12","current":-0.825545,"twenty":-3.177383,"median":-2.032036,"eighty":-1.313722,"marketCap":8398270.48},{"date":"2023-05-19","current":-0.85918,"twenty":-3.172518,"median":-2.018853,"eighty":-1.296669,"marketCap":8740434.2},{"date":"2023-05-26","current":-0.869948,"twenty":-3.15404,"median":-2.004482,"eighty":-1.288709,"marketCap":8849981},{"date":"2023-06-02","current":-0.954408,"twenty":-3.147108,"median":-1.997382,"eighty":-1.286506,"marketCap":9819909.94},{"date":"2023-06-09","current":-1.075428,"twenty":-3.136195,"median":-1.991218,"eighty":-1.264061,"marketCap":11065080.62},{"date":"2023-06-16","current":-1.205401,"twenty":-3.12355,"median":-1.978578,"eighty":-1.246579,"marketCap":12402369.98},{"date":"2023-06-23","current":-1.246116,"twenty":-3.116734,"median":-1.975785,"eighty":-1.244486,"marketCap":12821282.57},{"date":"2023-06-30","current":-1.256956,"twenty":-3.093516,"median":-1.964078,"eighty":-1.240857,"marketCap":12932818.39},{"date":"2023-07-07","current":-1.184097,"twenty":-3.077479,"median":-1.957077,"eighty":-1.235093,"marketCap":12183177.32},{"date":"2023-07-14","current":-1.184872,"twenty":-3.068549,"median":-1.94874,"eighty":-1.223729,"marketCap":12191143.24},{"date":"2023-07-21","current":-1.219707,"twenty":-3.064034,"median":-1.941278,"eighty":-1.219707,"marketCap":12549563.3},{"date":"2023-07-28","current":-1.151476,"twenty":-3.049957,"median":-1.933873,"eighty":-1.206848,"marketCap":11847532.38},{"date":"2023-08-04","current":-1.162123,"twenty":-3.044964,"median":-1.923626,"eighty":-1.205338,"marketCap":11957085.99},{"date":"2023-08-11","current":-1.122385,"twenty":-3.034685,"median":-1.918645,"eighty":-1.195484,"marketCap":11548221.54},{"date":"2023-08-18","current":-1.036854,"twenty":-3.028315,"median":-1.916062,"eighty":-1.186318,"marketCap":10668188.61},{"date":"2023-08-25","current":-1.066809,"twenty":-3.021126,"median":-1.912932,"eighty":-1.184016,"marketCap":10976402.48},{"date":"2023-09-01","current":-1.095702,"twenty":-3.013065,"median":-1.909848,"eighty":-1.1754,"marketCap":11273683.27},{"date":"2023-09-08","current":-1.17464,"twenty":-3.003784,"median":-1.906899,"eighty":-1.174062,"marketCap":11473886.55},{"date":"2023-09-15","current":-1.147716,"twenty":-2.996908,"median":-1.903497,"eighty":-1.171418,"marketCap":11210886.27},{"date":"2023-09-22","current":-1.11691,"twenty":-2.987786,"median":-1.90035,"eighty":-1.166957,"marketCap":10909976.42},{"date":"2023-09-29","current":-1.076698,"twenty":-2.977753,"median":-1.89779,"eighty":-1.165356,"marketCap":10517181.78},{"date":"2023-10-06","current":-1.037725,"twenty":-2.966245,"median":-1.891164,"eighty":-1.16185,"marketCap":10136497.79},{"date":"2023-10-13","current":-0.979261,"twenty":-2.950661,"median":-1.889234,"eighty":-1.157563,"marketCap":9565426.12},{"date":"2023-10-20","current":-0.929548,"twenty":-2.938035,"median":-1.882448,"eighty":-1.151448,"marketCap":9079819.37},{"date":"2023-10-27","current":-0.767492,"twenty":-2.929162,"median":-1.879919,"eighty":-1.149988,"marketCap":7496862.28},{"date":"2023-11-03","current":-0.881165,"twenty":-2.909234,"median":-1.875841,"eighty":-1.146266,"marketCap":8607214.71},{"date":"2023-11-10","current":-0.881049,"twenty":-2.888467,"median":-1.868108,"eighty":-1.136266,"marketCap":8606086.61},{"date":"2023-11-17","current":-0.870691,"twenty":-2.861142,"median":-1.865377,"eighty":-1.12663,"marketCap":8504906.53},{"date":"2023-11-24","current":-0.904034,"twenty":-2.848996,"median":-1.861976,"eighty":-1.122385,"marketCap":8830603.2},{"date":"2023-12-01","current":-1.021606,"twenty":-2.834434,"median":-1.85898,"eighty":-1.11959,"marketCap":9195475.92},{"date":"2023-12-08","current":-0.993592,"twenty":-2.811155,"median":-1.857289,"eighty":-1.113215,"marketCap":8943320.08},{"date":"2023-12-15","current":-0.96604,"twenty":-2.779515,"median":-1.854402,"eighty":-1.107221,"marketCap":8695328.75},{"date":"2023-12-22","current":-1.013518,"twenty":-2.754894,"median":-1.850258,"eighty":-1.096603,"marketCap":9122674.96},{"date":"2023-12-29","current":-1.013434,"twenty":-2.750442,"median":-1.847048,"eighty":-1.093848,"marketCap":9121920.06},{"date":"2024-01-05","current":-1.004622,"twenty":-2.7401,"median":-1.8454,"eighty":-1.088291,"marketCap":9042603.36},{"date":"2024-01-12","current":-1.394787,"twenty":-2.713383,"median":-1.841521,"eighty":-1.081564,"marketCap":12554474.79},{"date":"2024-01-19","current":-1.340106,"twenty":-2.693542,"median":-1.84022,"eighty":-1.081559,"marketCap":12062298.71},{"date":"2024-01-26","current":-1.416047,"twenty":-2.672029,"median":-1.837546,"eighty":-1.081564,"marketCap":12745835.36},{"date":"2024-02-02","current":-1.484107,"twenty":-2.661007,"median":-1.832655,"eighty":-1.081564,"marketCap":13358445.57},{"date":"2024-02-09","current":-1.47051,"twenty":-2.643764,"median":-1.825875,"eighty":-1.081564,"marketCap":13236059.94},{"date":"2024-02-16","current":-1.44654,"twenty":-2.631362,"median":-1.822434,"eighty":-1.081564,"marketCap":13020302.58},{"date":"2024-02-23","current":-1.441168,"twenty":-2.623756,"median":-1.816932,"eighty":-1.081564,"marketCap":12971955.88},{"date":"2024-03-01","current":-1.466294,"twenty":-2.611354,"median":-1.814202,"eighty":-1.08157,"marketCap":13198113.84},{"date":"2024-03-08","current":-1.517721,"twenty":-2.60192,"median":-1.810593,"eighty":-1.08157,"marketCap":13661004.99},{"date":"2024-03-15","current":-1.489592,"twenty":-2.591185,"median":-1.800955,"eighty":-1.08157,"marketCap":13407815.65},{"date":"2024-03-22","current":-1.567375,"twenty":-2.571491,"median":-1.797932,"eighty":-1.08157,"marketCap":14107940.61},{"date":"2024-03-28","current":-1.53878,"twenty":-2.560055,"median":-1.793607,"eighty":-1.08157,"marketCap":13850558.22},{"date":"2024-04-05","current":-1.33946,"twenty":-2.55098,"median":-1.788293,"eighty":-1.081564,"marketCap":10225439.63},{"date":"2024-04-12","current":-1.410586,"twenty":-2.525765,"median":-1.785058,"eighty":-1.081564,"marketCap":10768413.07},{"date":"2024-04-19","current":-1.343454,"twenty":-2.521177,"median":-1.776906,"eighty":-1.081564,"marketCap":10255925.59},{"date":"2024-04-26","current":-1.340099,"twenty":-2.520935,"median":-1.766933,"eighty":-1.08157,"marketCap":10230318.8},{"date":"2024-05-03","current":-1.368109,"twenty":-2.520935,"median":-1.755483,"eighty":-1.08157,"marketCap":10444148.11},{"date":"2024-05-10","current":-1.421378,"twenty":-2.520935,"median":-1.73262,"eighty":-1.08157,"marketCap":10850795.64},{"date":"2024-05-17","current":-1.379174,"twenty":-2.520935,"median":-1.728811,"eighty":-1.08157,"marketCap":10528614.32},{"date":"2024-05-24","current":-1.494766,"twenty":-2.520935,"median":-1.726503,"eighty":-1.083389,"marketCap":11411040.12},{"date":"2024-05-31","current":-1.428895,"twenty":-2.520935,"median":-1.726503,"eighty":-1.083389,"marketCap":10908187.12},{"date":"2024-06-07","current":-1.526542,"twenty":-2.520935,"median":-1.726503,"eighty":-1.083389,"marketCap":11653619.82},{"date":"2024-06-14","current":-1.952636,"twenty":-2.520935,"median":-1.730246,"eighty":-1.083389,"marketCap":14906421.79},{"date":"2024-06-21","current":-1.735795,"twenty":-2.521177,"median":-1.73712,"eighty":-1.082936,"marketCap":13251056.75},{"date":"2024-06-28","current":-1.722673,"twenty":-2.523834,"median":-1.746707,"eighty":-1.08157,"marketCap":13150883.73},{"date":"2024-07-05","current":-1.628324,"twenty":-2.523834,"median":-1.756078,"eighty":-1.08157,"marketCap":12430625.4},{"date":"2024-07-12","current":-2.263973,"twenty":-2.523834,"median":-1.767562,"eighty":-1.08157,"marketCap":17283171.91},{"date":"2024-07-15","current":-2.39761,"twenty":-2.523834,"median":-1.769436,"eighty":-1.08157,"marketCap":18303358.28},{"date":"2024-08-02","current":-2.226195,"twenty":-2.534528,"median":-1.783114,"eighty":-1.079223,"marketCap":16994768.67},{"date":"2024-08-09","current":-1.891964,"twenty":-2.534528,"median":-1.787653,"eighty":-1.079223,"marketCap":14443251.53},{"date":"2024-08-16","current":-2.078982,"twenty":-2.534528,"median":-1.792531,"eighty":-1.079223,"marketCap":15870948.86},{"date":"2024-08-23","current":-2.003096,"twenty":-2.534528,"median":-1.797682,"eighty":-1.079223,"marketCap":15291631.74},{"date":"2024-08-30","current":-1.965032,"twenty":-2.534528,"median":-1.800699,"eighty":-1.08111,"marketCap":15001053.7},{"date":"2024-09-06","current":-1.940828,"twenty":-2.534528,"median":-1.805453,"eighty":-1.091337,"marketCap":14305846.53},{"date":"2024-09-13","current":-1.865551,"twenty":-2.534528,"median":-1.812487,"eighty":-1.095702,"marketCap":13750972.58},{"date":"2024-09-20","current":-1.985608,"twenty":-2.534528,"median":-1.815855,"eighty":-1.102214,"marketCap":14635913.54},{"date":"2024-09-27","current":-1.874953,"twenty":-2.534528,"median":-1.822078,"eighty":-1.112462,"marketCap":13820277.56},{"date":"2024-10-04","current":-1.896454,"twenty":-2.534528,"median":-1.825291,"eighty":-1.117888,"marketCap":13978762.2},{"date":"2024-10-11","current":-2.06438,"twenty":-2.534528,"median":-1.830388,"eighty":-1.122385,"marketCap":15216547.2},{"date":"2024-10-18","current":-2.302644,"twenty":-2.534528,"median":-1.834816,"eighty":-1.12689,"marketCap":16972789.68},{"date":"2024-10-25","current":-2.557021,"twenty":-2.555048,"median":-1.838102,"eighty":-1.137455,"marketCap":18847804.94},{"date":"2024-10-31","current":-2.074806,"twenty":-2.555048,"median":-1.840606,"eighty":-1.146862,"marketCap":15293394.35},{"date":"2024-11-08","current":-2.085001,"twenty":-2.555244,"median":-1.843878,"eighty":-1.149601,"marketCap":15368545.15},{"date":"2024-11-15","current":-2.00349,"twenty":-2.555244,"median":-1.845932,"eighty":-1.151476,"marketCap":14767721.02},{"date":"2024-11-22","current":-1.940397,"twenty":-2.555244,"median":-1.849792,"eighty":-1.154709,"marketCap":14302668.6},{"date":"2024-11-29","current":-2.049501,"twenty":-2.555244,"median":-1.851642,"eighty":-1.154709,"marketCap":15106869.68},{"date":"2024-12-06","current":-1.46331,"twenty":-2.555244,"median":-1.85334,"eighty":-1.157331,"marketCap":10786057.16},{"date":"2024-12-13","current":-1.477425,"twenty":-2.555244,"median":-1.85334,"eighty":-1.160777,"marketCap":10890097.86},{"date":"2024-12-20","current":-1.368506,"twenty":-2.555244,"median":-1.85334,"eighty":-1.162123,"marketCap":10087261.14},{"date":"2024-12-27","current":-1.365213,"twenty":-2.555244,"median":-1.85334,"eighty":-1.165951,"marketCap":10062983.07},{"date":"2025-01-03","current":-1.517858,"twenty":-2.555244,"median":-1.85334,"eighty":-1.166793,"marketCap":11188129.99},{"date":"2025-01-10","current":-1.515494,"twenty":-2.555599,"median":-1.854017,"eighty":-1.168307,"marketCap":11170704.43},{"date":"2025-01-17","current":-2.244356,"twenty":-2.555599,"median":-1.856708,"eighty":-1.17464,"marketCap":16543146.59},{"date":"2025-01-24","current":-2.159014,"twenty":-2.555599,"median":-1.857482,"eighty":-1.177316,"marketCap":15914094.79},{"date":"2025-01-31","current":-2.165047,"twenty":-2.555599,"median":-1.860251,"eighty":-1.184872,"marketCap":15958563.84},{"date":"2025-02-07","current":-2.068144,"twenty":-2.555599,"median":-1.862292,"eighty":-1.195355,"marketCap":15244290.75},{"date":"2025-02-14","current":-2.17422,"twenty":-2.555599,"median":-1.865762,"eighty":-1.206121,"marketCap":16026179.19},{"date":"2025-02-21","current":-2.29742,"twenty":-2.555599,"median":-1.867241,"eighty":-1.218933,"marketCap":16934284.15},{"date":"2025-02-28","current":-2.283591,"twenty":-2.555599,"median":-1.870527,"eighty":-1.2283,"marketCap":16832350.36},{"date":"2025-03-07","current":-2.149373,"twenty":-2.555955,"median":-1.876435,"eighty":-1.236334,"marketCap":15843027.93},{"date":"2025-03-14","current":-2.117074,"twenty":-2.555955,"median":-1.880443,"eighty":-1.243488,"marketCap":15604956.15},{"date":"2025-03-21","current":-2.104425,"twenty":-2.555955,"median":-1.885307,"eighty":-1.25624,"marketCap":15511718.86},{"date":"2025-03-28","current":-2.109237,"twenty":-2.555955,"median":-1.889558,"eighty":-1.277191,"marketCap":15547186.76},{"date":"2025-04-04","current":-2.161519,"twenty":-2.555955,"median":-1.891431,"eighty":-1.288296,"marketCap":15932558.38},{"date":"2025-04-11","current":-2.018491,"twenty":-2.555599,"median":-1.893817,"eighty":-1.313534,"marketCap":14878293.59},{"date":"2025-04-17","current":-2.142187,"twenty":-2.555599,"median":-1.897777,"eighty":-1.313534,"marketCap":16880431.15}],"updateTime":1745134291425}}}